2017
DOI: 10.1016/j.jocn.2017.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Multiple sclerosis: Frequency, cost, and economic burden in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(20 citation statements)
references
References 11 publications
1
18
0
1
Order By: Relevance
“…Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS) that affects more than 2.5 million people worldwide. 1 In MS, inflammation, demyelination and neurodegeneration are considered to contribute to disease development. 2 , 3 It is assumed that in MS, a misguided immune response against the CNS is initiated and orchestrated by autoreactive T cells, leading to progressive demyelination, oligodendrocyte injury and axonal loss, 4 , 5 that affect not only the white but also the grey matter.…”
Section: Introductionmentioning
confidence: 99%
“…Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS) that affects more than 2.5 million people worldwide. 1 In MS, inflammation, demyelination and neurodegeneration are considered to contribute to disease development. 2 , 3 It is assumed that in MS, a misguided immune response against the CNS is initiated and orchestrated by autoreactive T cells, leading to progressive demyelination, oligodendrocyte injury and axonal loss, 4 , 5 that affect not only the white but also the grey matter.…”
Section: Introductionmentioning
confidence: 99%
“…MS is associated with high social and economic burden and increases over time. The economic burden associated with MS in Europe was estimated to be approximately 14.6 billion euros in 2010, and the United States bore the associated costs of approximately $4.3 billion in 2013 ( 99 ). Although the etiology of MS is currently unknown, many disease-related risk factors have been identified.…”
Section: Gene Polymorphisms and Autoimmune Diseasesmentioning
confidence: 99%
“…It results in a heterogeneous array of outcomes that can compromise quality of life. 1 One of the most common and impactful results of MS is cognitive dysfunction, affecting nearly two-thirds of persons with MS. 2 Cognitive dysfunction typically manifests as impaired information processing speed, learning and memory, and/or executive function. 2,3 Although there may be multiple mechanisms contributing to cognitive dysfunction in MS, cerebrovascular dysfunction may play an underappreciated role in this setting.…”
Section: O N L I N E F I R S Tmentioning
confidence: 99%